LUGPA Policy Alert – New Joint Survey Shows Escalating Insurer Downcoding Threatening Independent Specialty Practices

March 2026 

At-a-Glance Essentials

What’s Changing
A new joint survey from LUGPA and the Community Oncology Alliance (COA) finds that insurer downcoding of Evaluation & Management (E/M) services is rapidly increasing across independent urology and oncology practices.

Why It Matters

• 75% of respondents report that downcoding has increased over the past year
• 85% say they are frequently required to submit medical records during appeals
• Practices report thousands of claims downgraded, often by automated payer algorithms without clinical review

Action Points

• LUGPA is using these findings to strengthen advocacy for payer transparency and fair reimbursement
• Members are encouraged to track denial patterns, document trends, and continue appealing downcoded claims

Key Takeaway
The survey shows that downcoding has become a systemic and growing payer practice threatening the sustainability of independent specialty care.

Overview

LUGPA and COA conducted a targeted survey of independent specialty practices to assess the scope and impact of payer downcoding—the practice of insurers unilaterally reducing E/M code levels (e.g., 99214 to 99213 or 99205 to 99204), often without reviewing clinical documentation.

The results point to a rapidly escalating issue affecting physician-led practices, driven in part by automated claim review systems and increasingly aggressive payer oversight.

Survey Highlights

Respondent Profile

• 92.9% of respondents work in independent urology or oncology/hematology practices
• 7.1% are outside the independent practice setting

Downcoding Is Increasing

• 75% report increased downcoding compared to one year ago
• 19% report no change
• 1.5% report a decrease

This trend suggests payer reliance on automated or algorithm-driven claim edits is expanding.

Appeals Require Extensive Documentation

• 85% of respondents frequently must submit medical records during appeals
• Only 3.3% report never needing to provide documentation

While many appeals are ultimately successful, they often require significant time and staff resources. One practice reported reviewing 100 downcoded charts and found 98 were originally coded correctly, raising serious concerns about payer accuracy.

Administrative and Operational Burden

Survey responses describe downcoding as widespread and disruptive to practice operations. Reported challenges include:

• Thousands of downgraded claims creating billing delays and revenue disruption
• E/M services routinely reduced from Level 4–5 visits to Level 3
• Denials of modifier 25 claims tied to global surgical edits
• Automated downcoding by major national insurers, including Medicare Advantage plans

Practices report dedicating substantial staff time to navigating appeals through payer portals, significantly increasing administrative costs.

In response, some practices are evaluating more significant actions, including:

• Filing complaints with state regulators
• Reassessing participation in certain payer networks
• Reducing ancillary service offerings

Why Downcoding Matters

Revenue Erosion
E/M services are foundational to outpatient specialty care. Routine downgrading reduces reimbursement for medically necessary, properly documented services.

Administrative Cost Shifting
Even when appeals succeed, the burden of proof and administrative cost is shifted to physician practices—diverting resources away from patient care.

Pressure Toward Consolidation
Sustained financial and operational strain may accelerate consolidation, as independent practices struggle to compete with hospital-owned systems that benefit from higher reimbursement rates.

This dynamic can:

• Increase overall healthcare costs
• Reduce patient choice
• Limit access to community-based specialty care

Implications for LUGPA Members

The survey underscores the growing impact of downcoding on independent urology practices. Members report:

• Reduced revenue tied to complex patient visits
• Increased workload for billing and revenue-cycle teams
• Strategic pressure to reconsider payer relationships
• Workflow disruptions affecting staffing and efficiency

For many practices, downcoding now ranks alongside prior authorization and site-of-service payment disparities as one of the most significant threats to sustainability.

LUGPA Advocacy

LUGPA is actively working to address payer downcoding through:

• Engagement with insurers on algorithm-driven E/M reductions without clinical review
• Advocacy for greater transparency and due process in claim review programs
• Development of member resources to identify, track, and appeal denials

These survey results provide critical, data-driven support for ongoing advocacy efforts at both the state and federal levels.

Next Steps

LUGPA will use these findings to advance policy solutions, including:

• Requiring clinical documentation review prior to downcoding
• Establishing clear timelines and standards for appeals
• Increasing transparency around automated claim review systems
• Holding payers accountable for patterns of inappropriate claim reductions

LUGPA will continue working with stakeholders to ensure reimbursement policies support independent practices and protect patient access to care.

Bottom Line

The LUGPA–COA survey demonstrates that payer downcoding is no longer an isolated billing issue—it is a widespread, systemic, and escalating practice. Without reform, it will continue to impose significant financial and administrative strain on independent specialty practices and threaten the viability of physician-led, community-based care.